Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
Outline of Final Research Achievements |
The recombinant virus proteins are used for vaccinations and diagnostic reagent kits and their low cost productions are required. In this study, efficient virus protein production system was developed in yeast. When hepatitis B virus surface protein HBsL was expressed in yeast, it was degraded rapidly. We constructed highly stable HBsL mutants and also an expression system that enable stable virus protein production in yeast. These results provide strategies for the problems of virus infection that will emerge in the future.
|